Tumor-Infiltrating Clonal Hematopoiesis Increased Risk of Poor Outcomes in Cancer
(MedPage Today) — Tumor-infiltrating clonal hematopoiesis (TI-CH) increased the risk of disease recurrence or death among patients with early non-small cell lung cancer (NSCLC), and the risk of death from any cause among patients with solid tumors…
